People
The Biotechnology Institute gave its newly launched 2018 Woman of the Year Award to Seema Kumar.
Since Allogene Therapeutics launched in April the company has been rapidly expanding its leadership team as it drives forward with a mission of developing allogeneic CAR-T therapies.
Not only are women generally underrepresented in the biopharma industry, but compared to many of the top male executives, underpaid. Here’s a closer look at the top five female executives by pay in the biopharma industry.
A former biotech analyst who was charged with insider trading last fall will spend four months in prison this fall after pleading guilty to one count of securities fraud.
Biotech companies continue to make moves to strengthen senior leadership teams and drive growth. Here is a roundup of some noted movers and shakers for the week of June 11 - 15.
If convicted Holmes and Balwani face a maximum sentence of 20 years in prison.
More management changes are happening at GlaxoSmithKline. This morning the company said longtime senior executive Luc Debruyne is stepping down from his role at the end of the year.
Biotech and pharmaceutical companies across the U.S. and globally shook up their senior leadership roles in the first week of June with new hires that included chief executive officers and directors.
Gilmore O’Neill, formerly Biogen’s senior vice president, late-stage clinical development, jumped ship and will be Sarepta Therapeutics’ chief medical officer.
In a recent interview, Ron Cohen, chief executive officer of Acorda Therapeutics, indicated that if the company lost its appeals over patent lawsuits for its Ampyra for multiple sclerosis, there would not be layoffs in its sales force.
PRESS RELEASES